<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d498" origId="Edrophonium"><sentence id="DrugDDI.d498.s0" origId="s0" text="Care should be given when administering this drug to patients with symptoms of myasthenic weakness who are also on anticholinesterase drugs."><entity id="DrugDDI.d498.s0.e0" origId="s0.p6" charOffset="45-49" type="drug" text="drug"/><entity id="DrugDDI.d498.s0.e1" origId="s0.p13" charOffset="115-139" type="drug" text="anticholinesterase drugs"/><pair id="DrugDDI.d498.s0.p0" e1="DrugDDI.d498.s0.e0" e2="DrugDDI.d498.s0.e1" interaction="true"/></sentence><sentence id="DrugDDI.d498.s1" origId="s1" text="Since symptoms of anticholinesterase overdose (cholinergic crisis) may mimic underdosage (myasthenic weakness), their condition may be worsened by the use of this drug."><entity id="DrugDDI.d498.s1.e0" origId="s1.p32" charOffset="163-167" type="drug" text="drug"/></sentence></document>